1. A budget impact model for biosimilar infliximab in Crohn's disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia. (2nd January 2016) Authors: Brodszky, Valentin; Rencz, Fanni; Péntek, Márta; Baji, Petra; Lakatos, Péter L; Gulácsi, László Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 16:Number 1(2016) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bleeding out the quality-adjusted life years: evaluating the burden of primary dysmenorrhea using time trade-off and willingness-to-pay methods. Issue 11 (November 2017) Authors: Rencz, Fanni; Péntek, Márta; Stalmeier, Peep F.M.; Brodszky, Valentin; Ruzsa, Gábor; Gradvohl, Edina; Baji, Petra; Gulácsi, László Journal: Pain Issue: Volume 158:Issue 11(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe. Issue 2 (March 2018) Authors: Baji, Petra; Gulácsi, László; Brodszky, Valentin; Végh, Zsuzsanna; Danese, Silvio; Irving, Peter M; Peyrin-Biroulet, Laurent; Schreiber, Stefan; Rencz, Fanni; Lakatos, Péter L; Péntek, Márta Journal: United European Gastroenterology journal Issue: Volume 6:Issue 2(2018) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cost-utility of biological treatment sequences for luminal Crohn's disease in Europe. (2nd November 2017) Authors: Rencz, Fanni; Gulácsi, László; Péntek, Márta; Gecse, Krisztina B.; Dignass, Axel; Halfvarson, Jonas; Gomollón, Fernando; Baji, Petra; Peyrin-Biroulet, Laurent; Lakatos, Peter L.; Brodszky, Valentin Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 17:Number 6(2017) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost‐effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe. Issue 2 (1st March 2018) Authors: Baji, Petra; Gulácsi, László; Brodszky, Valentin; Végh, Zsuzsanna; Danese, Silvio; Irving, Peter M; Peyrin‐Biroulet, Laurent; Schreiber, Stefan; Rencz, Fanni; Lakatos, Péter L; Péntek, Márta Journal: United European Gastroenterology journal Issue: Volume 6:Issue 2(2018) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic. (8th November 2022) Authors: Koszorú, Kamilla; Hajdu, Krisztina; Brodszky, Valentin; Szabó, Ákos; Borza, Júlia; Bodai, Katalin; Pónyai, Györgyi; Szegedi, Andrea; Sárdy, Miklós; Rencz, Fanni Journal: Dermatitis Issue: Volume 33:(2022)Supplement 6 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis. (3rd September 2019) Authors: Zrubka, Zsombor; Gulácsi, László; Brodszky, Valentin; Rencz, Fanni; Alten, Rieke; Szekanecz, Zoltán; Péntek, Márta Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 19:Number 5(2019) Page Start: 537 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Musculoskeletal health and capability wellbeing: Associations between the HAQ-DI, ICECAP-A and ICECAP-O measures in a population survey. (October 2021) Authors: Péntek, Márta; Poór, Gyula; Gulácsi, László; Zrubka, Zsombor; Brodszky, Valentin; Rencz, Fanni; Dobos, Ágota; Farkas, Miklós; Kovács, Levente; Baji, Petra Journal: Musculoskeletal science and practice Issue: Volume 55(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Patients' access to biological therapy in chronic inflammatory conditions; per capita GDP does not explain the intercountry differences. Issue 5 (17th February 2016) Authors: Gulácsi, László; Rencz, Fanni; Poór, Gyula; Szekanecz, Zoltán; Brodszky, Valentin; Baji, Petra; Péntek, Márta Journal: Annals of the rheumatic diseases Issue: Volume 75:Issue 5(2016) Page Start: 942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study. (3rd April 2022) Authors: Gáspár, Krisztián; Hunor Gergely, L.; Jenei, Balázs; Wikonkál, Norbert; Kinyó, Ágnes; Szegedi, Andrea; Remenyik, éva; Kiss, Norbert; Jin, Xiang; Sárdy, Miklós; Beretzky, Zsuzsanna; Péntek, Márta; Gulácsi, László; Bánvölgyi, András; Brodszky, Valentin; Rencz, Fanni Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 22:Number 3(2022) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗